secwatch.observer — SEC 8-K summary
======================================

Issuer:     Entera Bio Ltd. (ENTXW)
CIK:        0001638097
Form:       8-K
Filed at:   2024-03-04T23:59:59+00:00
Accession:  0001178913-24-000794
Event type: regulatory
Sentiment:  positive
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Entera Bio regains Nasdaq minimum bid price compliance, delisting risk removed
------------------------------------------------------------------------------

- Received Nasdaq notice on March 1, 2024 confirming bid price compliance.
- Ordinary shares closed at $1.00+ for 10 consecutive business days to satisfy rule.
- Listing matter is now closed; no further action required.
- Press release issued March 4, 2024 announcing the compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638097/000117891324000794/0001178913-24-000794-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638097/000117891324000794/zk2431079.htm
  HTML page:      https://secwatch.observer/filing/0001178913-24-000794

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer